Clinical Study Administering SHED for Hypoganglionosis Adopted by AMED
NQ Score
80/100
N1 Content Completeness
8
AI Summary (NQ-processed)
S-Quatre, a Kids Well Bio group company, announced that a joint clinical research project with Kyushu University using SHED stem cells to treat hypoganglionosis has been adopted by AMED.